hodgkin lymphoma
Showing NaN - NaN of 9
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Participated in Children's Oncology Group Studies
Recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- Assessment of Therapy Complications
- Questionnaire Administration
-
Birmingham, Alabama
- +163 more
Sep 6, 2022
Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)
Not yet recruiting
- Hematologic Malignancy
- +10 more
- Tagraxofusp
- +8 more
-
Los Angeles, California
- +28 more
Jul 26, 2022
Hodgkin Lymphoma Trial in Philadelphia (Nivolumab)
Terminated
- Hodgkin Lymphoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
May 20, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)
Recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Hematopoietic Cell Transplantation
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Hodgkin Lymphoma Trial in Philadelphia (CD19 RNA redirected autologous T-cells (RNA CART19 cells))
Terminated
- Hodgkin Lymphoma
- CD19 RNA redirected autologous T-cells (RNA CART19 cells)
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
May 19, 2020
Positron-Emission Tomography, Immunomodulation, Metastatic Solid Malignancies Trial in Scottsdale, New York, Philadelphia
Completed
- Positron-Emission Tomography
- +3 more
- ⁸⁹Zr-Df-IAB22M2C Infusion
-
Scottsdale, Arizona
- +2 more
Sep 17, 2018
Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (XmAb2513)
Completed
- Hodgkin Lymphoma
- Anaplastic Large Cell Lymphoma
- XmAb2513
-
Chicago, Illinois
- +3 more
Apr 18, 2014